AI-Assisted Triage for Intracranial Hemorrhage
Detect ICH in non-contrast head CT,
in seconds, at the point of scan.
No cloud. On-site available.
RocSite ICH flags suspected hemorrhage across five subtypes to help radiologists prioritize worklists. On-premises deployment. No PHI transmitted. How the passport is produced: ICH names the imaging event, binds the grade to the checkpoint, and keeps the record offline. Q253397 is pedigree, not a second company.
0.9592
AUC-ROC
92.5%
Sensitivity
98.5%
NPV
Partner evaluation concluded
Thank you. The demo is complete.
The open partner evaluation of ICH Triage has wrapped, and the feedback was amazing. To every radiologist, emergency physician, and health-system team who ran cases, pushed the model hard, and told us exactly what they saw: thank you for your support. You made the product sharper and the evidence stronger.
ICH Triage now moves forward on the FDA Class II SaMD pathway, with the Pre-Submission accepted in January 2026. If you want to be part of what comes next, we would love to hear from you.
Talk to us about what’s next →
Performance metrics reflect preliminary internal validation studies.
RocSite ICH is not approved for clinical use. Partner evaluation concluded; FDA Class II SaMD pathway in progress.
RocSite ICH is not approved for clinical use. Partner evaluation concluded; FDA Class II SaMD pathway in progress.
Demonstration mode. Pre-loaded cases use synthetic data. Upload your own DICOM for real model inference.
A note from the founder
You might have ICH already.
This one works 100% offline, no cloud, with results in milliseconds. Can I get your support?
We also build AI Governance Tools for regulated environments, see
rocsitediscovery.com
See it in action
Select a synthetic demonstration case or upload your own DICOM for real inference.
IPH👁
SDH👁
EDH👁
SAH👁
IVH👁
Normal👁
Drop DICOM here
or click to browse · .dcm .dicom .zip
-
-
Running inference · On-premises
0
milliseconds
No PHI Transmitted
-
-
0%
PROB
ICH Probability
p=- · threshold=0.1152
Note: This is a synthetic demonstration case for illustration purposes.
No Flag <14%
Low 14–40%
Moderate 40–70%
High >70%
Subtype Breakdown
0.9592
AUC-ROC
92.5%
Sensitivity
85.0%
Specificity
98.5%
NPV
Preliminary validation study · Algorithm Locked · Validated AUC 0.9592
Clinical Evaluation Complete
The Technology Is Real. We Need Your Data.
We are seeking one hospital partner to provide de-identified head CT data for formal clinical validation under a research data sharing agreement.
Partner institutions receive:
✓ Named as a validation partner
✓ Co-authorship on validation paper
✓ Early access to cleared device
✓ Zero cost to your institution
✓ Co-authorship on validation paper
✓ Early access to cleared device
✓ Zero cost to your institution
Your Session
No analyses yet.
01
Letter of Support
Non-binding, one paragraph. Costs you nothing. Means everything to the program.
02
Tell Me I'm Wrong
30 minutes. Where does it fail? I want the hard critique before submission.
03
Be a Validation Site
Named validation partner, co-author credit, early access. No PHI leaves your institution.
04
One Name
A colleague who should see this. A site validator. A co-author reference.
Leave Your Assessment
What did you think? Where does this fail clinically? Goes directly to the founder.
✓
Thank you for evaluating.
the team will respond directly. Your assessment helps validate the system.
the RocSite team
RocSite AI
We sent you this key. Call, text, or email us directly, not a sales team, not a form.
This demonstration uses synthetic CT data for illustration purposes only. Performance metrics reflect preliminary internal validation studies and have not been formally validated in a clinical setting. RocSite ICH is not approved for clinical use. Partner evaluation concluded; FDA Class II SaMD pathway in progress.